Utah Medical Products Inc (UTMD) stock
UTMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/306% below fair value
$71.97−1.66 (-2.25%)
Close on Nov 13, 2026Market cap $229.14MP/E 21.5Yield –
Utah Medical Products EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Utah Medical Products's EV/EBITDA was 14.1× on Nov 11, 2026, against 7.1× a year earlier. Over the last 5 years it ranged from 6.6× to 16.7×, with a median of 11.9×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 14.1× | +7.1 |
| 2025 | Dec 31, 2025 | 7.0× | −0.8 |
| 2024 | Dec 31, 2024 | 7.8× | −4.4 |
| 2023 | Dec 29, 2023 | 12.1× | −2.7 |
| 2022 | Dec 30, 2022 | 14.9× | −1.8 |
| 2021 | Dec 31, 2021 | 16.7× | −1.8 |
| 2020 | Dec 31, 2020 | 18.5× | +4.0 |
| 2018 | Oct 31, 2018 | 14.5× | −0.2 |
| 2017 | Dec 29, 2017 | 14.7× | −0.1 |
| 2016 | Dec 30, 2016 | 14.8× | +2.5 |
| 2015 | Dec 31, 2015 | 12.3× | −1.2 |
| 2014 | Dec 31, 2014 | 13.5× | −0.4 |
| 2013 | Dec 31, 2013 | 13.9× | +4.7 |
| 2012 | Dec 31, 2012 | 9.2× | −0.7 |
| 2011 | Dec 30, 2011 | 9.9× | – |
See a number that looks wrong?